SlideShare una empresa de Scribd logo
1 de 20
Functional genomics and cancer subtyping
with a human cancer coessentiality network
Traver Hart
Laboratory of Jason Moffat
Donnelly Centre, U. Toronto
NetBio SIG, 11 July 2014
GI correlation networks
Costanzo & Baryshnikova, et al., 2010
GI correlation
networks
Gene a
Gene b
Gene c
Gene d
Gene e
Cellline1
Cellline2
Cellline3
Cellline4
Cellline5
Cellline12
Cellline6
Cellline7
Cellline8
Cellline9
Cellline10
Cellline11
Essential
Nonessential
In yeast, highly correlated profiles imply
shared gene function. Can be used to
infer function of unknown genes.
Hypothesis: Correlated essentiality
profiles across human cancer cell lines
(bottom) are analogous to correlated GI
profiles and imply shared function—
even if we don’t know the query strain
Corollary: Gene clusters can help
identify cell lines with similar
vulnerabilities, possibly leading to novel
classification
Dixon et al., 2009
Query strains
ArraygenesArraystrains
Query strains
Pooled library shRNA screens
Marcotte et al., 2012
Bayesian essentiality scoring
Hart et al., 2014
The “daisy model” & core essential genes
Hart et al., 2014
A quantitative measure of sensitivity
to RNAi perturbation
Correlation, Essentiality Score vs Expression
Density
Gene a
Gene b
Gene c
Gene d
Gene e
Cellline1
Cellline2
Cellline3
Cellline4
Cellline5
Cellline12
Cellline6
Cellline7
Cellline8
Cellline9
Cellline10
Cellline11
Essential
Nonessential
Query cell lines
Hart et al., 2014
Mean essentiality score
Std.Devessentialityscore
F-measure
Number of Cell Lines
NumberofCellLinesNumberofEssentialGenes
Optimize LLS vs KEGG
30 BrCa
Luminal
+ Her2
24 BrCa
Basal
34 OvCa
15 PDAC
Filtered data:
107 total screens
2,842 genes
Correlations at 1% FDR:
1,086 genes
F65
F50
No hairpin norm.
Achilles
Correlation pair rank
LogLikelihoodScore(vsKEGG)
4 other
866 genes
1,877 edges
Ribosome
Proteasome
Spliceosome
OxPhos
The Human
Coessentiality
Network
Network Clustering
Ribosome
Proteasome
Spliceosome
OxPhos
BRCA Luminal/HER2
BrCa/LUM+Her2
BrCa/Basal
OvCa
PDAC
2
Expression vs. Essentiality
Correlation coefficient
GENE CORR P-VAL
SPDEF 0.716 2.00e-17
FOXA1 0.624 6.73e-13
ERBB2 0.583 4.57e-11
MDM2 0.529 7.87e-09
TFAP2C 0.463 5.12e-07
FUBP1 0.428 4.33e-06
ESR1 0.411 9.39e-05
CCND1 0.410 1.17e-05
OxPhos Cluster
BrCa/LUM+Her2
BrCa/Basal
OvCa
PDAC
OxPhos Cluster
ATP5A1
ATP5B
COX17
CYC1
HCCS
UQCRC1
BCS1L
ICT1
PNPT1
SSBP1
SUPV3L1
TMED2
TMEM79
ECSIT
NDUFA10
NDUFA11
NDUFAB1
NDUFS1
NDUFV1
MRPL21
MRPL22
MRPL23
MRPL51
MRPS11
ICT1
Functional genomics
(MLL2)
Homolog of GrpE,
NEF of Hsp70-type
ATPases
Mitochondrial
Hsp70 family
Conclusions:
• The human cancer coessentiality network
– Depends critically on the new scoring scheme derived from Hart et al, 2014
– Optimized by lessons learned from the yeast GI network
• Clusters identify cell lines with common genetic vulnerabilities
– Known and novel
• Co-essentiality implies Co-functionality
– A unique functional genomics resource
Open questions:
• Identify genomic drivers of validated clusters?
• Improve coverage?
• Improve accuracy? CRISPR?
Robert Rottapel
Fabrice Sirculomb
Fernando Suarez
Mauricio Medrano
Josee Normand
Jason Moffat
Troy Ketela
Kevin Brown
Judice Koh
Glauber Brito
Azin Sayid
Dina Karamboulas
Dewald Van Dyk
Dahlia Kasimer
Christine Misquitta
Acknowledgements
Essentiality Screens in Cancer Cell Lines
18
Yaroslav Fedyshyn
Marianna Luhova
Bohdana Fedyshyn
Patricia Mero
Christine Misquitta
Franco Vizeacoumar
Benjamin Neel
Richard Marcotte
Azin Sayad
CoEssential +
CoElution
850 PPI
218 neg
313?
17 PPI
60 neg
236 ?
Vs CORUM
Vs GO_CC
GENE1 GENE2 CoEss CoElu GO_CC? Notes
DLST OGDH 0.75 0.97 ? aKG dehydrogenase
MRPL22 MRPL23 0.66 0.52 0 Mitochondrial
EIF2B2 EIF2B3 0.62 0.91 1 EIF2B complex
MRPL23 SSBP1 0.59 0.70 ? Mitochondrial
HCCS SSBP1 0.57 0.42 ? Mitochondrial
NACA RPLP2 0.56 0.61 ? Translation
ICT1 MRPL22 0.55 0.68 0 Mitochondrial
ATP5B CYC1 0.53 0.59 ? Mitochondrial
ICT1 PTCD3 0.53 0.70 ? Mitochondrial
EML4 MAU2 0.52 0.41 0 Microtubule associated protein / sister
chromatid cohesion factor
NSMCE1 SMC5 0.52 0.51 1 SMC5/6 complex
COPB2 COPG1 0.51 0.98 1 Coatomer complex
NUTF2 RAN 0.50 0.73 1 Nuclear pore/transport
NUP205 NUP93 0.50 0.61 1 Nuclear pore/transport
ATP5A1 CYC1 0.50 0.79 ? Mitochondrial
ARCN1 COPB1 0.49 0.99 1 Coatomer complex
EBNA1BP2 NIFK 0.49 0.60 ? Ribosome biogenesis? Mitosis?
BRIX1 UTP15 0.49 0.80 ? Ribosome biogenesis
EIF3C PTBP3 0.48 0.47 ? EIF3 / Polypyrimidine (RNA) binding
GRPEL1 HSPA9 0.47 0.48 ? HSP70 + nucleotide exchange factor
CYC1 PTCD3 0.47 0.68 ? Mitochondrial
EIF5A HNRNPK 0.46 0.68 0 Translation / Splicing
CYC1 UQCRC1 0.45 0.41 ? Mitochondrial
CYC1 ECSIT 0.45 0.50 ? Mitochondrial
ATP5B UQCRC1 0.44 0.57 0 Mitochondrial
Why Gene Essentiality?
• Context-sensitive essentials are candidate therapeutic targets
Kaelin WG, Nat Rev Cancer, 2005
Wildtype A
Oncogenic a
Targeted b

Más contenido relacionado

La actualidad más candente

Raj Lab Meeting May/01/2019
Raj Lab Meeting May/01/2019Raj Lab Meeting May/01/2019
Raj Lab Meeting May/01/2019Ricardo Vialle
 
Bioinformatic Analysis of Synthetic Lethality in Breast Cancer
Bioinformatic Analysis of Synthetic Lethality in Breast CancerBioinformatic Analysis of Synthetic Lethality in Breast Cancer
Bioinformatic Analysis of Synthetic Lethality in Breast CancerTom Kelly
 
NetBioSIG2013-Talk Robin Haw
NetBioSIG2013-Talk Robin Haw NetBioSIG2013-Talk Robin Haw
NetBioSIG2013-Talk Robin Haw Alexander Pico
 
FunGen JC Presentation - Mostafavi et al. (2019)
FunGen JC Presentation - Mostafavi et al. (2019)FunGen JC Presentation - Mostafavi et al. (2019)
FunGen JC Presentation - Mostafavi et al. (2019)BrianSchilder
 
NetBioSIG2012 anyatsalenko-en-viz
NetBioSIG2012 anyatsalenko-en-vizNetBioSIG2012 anyatsalenko-en-viz
NetBioSIG2012 anyatsalenko-en-vizAlexander Pico
 
proteomics and system biology
proteomics and system biologyproteomics and system biology
proteomics and system biologyNawfal Aldujaily
 
Network Pharmacology Tri-Con 022212
Network Pharmacology Tri-Con 022212Network Pharmacology Tri-Con 022212
Network Pharmacology Tri-Con 022212Philip Bourne
 
STRING - Prediction of a functional association network for the yeast mitocho...
STRING - Prediction of a functional association network for the yeast mitocho...STRING - Prediction of a functional association network for the yeast mitocho...
STRING - Prediction of a functional association network for the yeast mitocho...Lars Juhl Jensen
 
NetBioSIG2014-Talk by Hyunghoon Cho
NetBioSIG2014-Talk by Hyunghoon ChoNetBioSIG2014-Talk by Hyunghoon Cho
NetBioSIG2014-Talk by Hyunghoon ChoAlexander Pico
 
Sundaram et al. 2018 Presentation
Sundaram et al. 2018 PresentationSundaram et al. 2018 Presentation
Sundaram et al. 2018 PresentationBrianSchilder
 
Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...Cresset
 
Drug Discovery: Proteomics, Genomics
Drug Discovery: Proteomics, GenomicsDrug Discovery: Proteomics, Genomics
Drug Discovery: Proteomics, GenomicsPhilip Bourne
 
dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020
dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020
dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020dkNET
 
Integration of heterogeneous data
Integration of heterogeneous dataIntegration of heterogeneous data
Integration of heterogeneous dataLars Juhl Jensen
 
Introduction to systems biology
Introduction to systems biologyIntroduction to systems biology
Introduction to systems biologylemberger
 
Novel network pharmacology methods for drug mechanism of action identificatio...
Novel network pharmacology methods for drug mechanism of action identificatio...Novel network pharmacology methods for drug mechanism of action identificatio...
Novel network pharmacology methods for drug mechanism of action identificatio...laserxiong
 

La actualidad más candente (20)

Raj Lab Meeting May/01/2019
Raj Lab Meeting May/01/2019Raj Lab Meeting May/01/2019
Raj Lab Meeting May/01/2019
 
PhD midterm report
PhD midterm reportPhD midterm report
PhD midterm report
 
Bioinformatic Analysis of Synthetic Lethality in Breast Cancer
Bioinformatic Analysis of Synthetic Lethality in Breast CancerBioinformatic Analysis of Synthetic Lethality in Breast Cancer
Bioinformatic Analysis of Synthetic Lethality in Breast Cancer
 
NetBioSIG2013-Talk Robin Haw
NetBioSIG2013-Talk Robin Haw NetBioSIG2013-Talk Robin Haw
NetBioSIG2013-Talk Robin Haw
 
FunGen JC Presentation - Mostafavi et al. (2019)
FunGen JC Presentation - Mostafavi et al. (2019)FunGen JC Presentation - Mostafavi et al. (2019)
FunGen JC Presentation - Mostafavi et al. (2019)
 
NetBioSIG2012 anyatsalenko-en-viz
NetBioSIG2012 anyatsalenko-en-vizNetBioSIG2012 anyatsalenko-en-viz
NetBioSIG2012 anyatsalenko-en-viz
 
proteomics and system biology
proteomics and system biologyproteomics and system biology
proteomics and system biology
 
Network Pharmacology Tri-Con 022212
Network Pharmacology Tri-Con 022212Network Pharmacology Tri-Con 022212
Network Pharmacology Tri-Con 022212
 
STRING - Prediction of a functional association network for the yeast mitocho...
STRING - Prediction of a functional association network for the yeast mitocho...STRING - Prediction of a functional association network for the yeast mitocho...
STRING - Prediction of a functional association network for the yeast mitocho...
 
NetBioSIG2014-Talk by Hyunghoon Cho
NetBioSIG2014-Talk by Hyunghoon ChoNetBioSIG2014-Talk by Hyunghoon Cho
NetBioSIG2014-Talk by Hyunghoon Cho
 
Sundaram et al. 2018 Presentation
Sundaram et al. 2018 PresentationSundaram et al. 2018 Presentation
Sundaram et al. 2018 Presentation
 
Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...
 
Drug Discovery: Proteomics, Genomics
Drug Discovery: Proteomics, GenomicsDrug Discovery: Proteomics, Genomics
Drug Discovery: Proteomics, Genomics
 
dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020
dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020
dkNET Webinar: Illuminating The Druggable Genome With Pharos 10/23/2020
 
Integration of heterogeneous data
Integration of heterogeneous dataIntegration of heterogeneous data
Integration of heterogeneous data
 
Ml in genomics
Ml in genomicsMl in genomics
Ml in genomics
 
Introduction to systems biology
Introduction to systems biologyIntroduction to systems biology
Introduction to systems biology
 
Systems biology
Systems biologySystems biology
Systems biology
 
Novel network pharmacology methods for drug mechanism of action identificatio...
Novel network pharmacology methods for drug mechanism of action identificatio...Novel network pharmacology methods for drug mechanism of action identificatio...
Novel network pharmacology methods for drug mechanism of action identificatio...
 
Structural genomics
Structural genomicsStructural genomics
Structural genomics
 

Similar a NetBioSIG2014-Talk by Traver Hart

OKC Grand Rounds 2009
OKC Grand Rounds 2009OKC Grand Rounds 2009
OKC Grand Rounds 2009Sean Davis
 
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...Sri Ambati
 
Genomics Technologies
Genomics TechnologiesGenomics Technologies
Genomics TechnologiesSean Davis
 
Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12
Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12
Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12Sage Base
 
20140613 Analysis of High Throughput DNA Methylation Profiling
20140613 Analysis of High Throughput DNA Methylation Profiling20140613 Analysis of High Throughput DNA Methylation Profiling
20140613 Analysis of High Throughput DNA Methylation ProfilingYi-Feng Chang
 
Ransbotyn et al PUBLISHED (1)
Ransbotyn et al PUBLISHED (1)Ransbotyn et al PUBLISHED (1)
Ransbotyn et al PUBLISHED (1)Tania Acuna
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicJoaquin Dopazo
 
Stephen Friend WIN Symposium 2011 2011-07-06
Stephen Friend WIN Symposium 2011 2011-07-06Stephen Friend WIN Symposium 2011 2011-07-06
Stephen Friend WIN Symposium 2011 2011-07-06Sage Base
 
Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...Ronak Shah
 
Friend EORTC 2012-11-08
Friend EORTC 2012-11-08Friend EORTC 2012-11-08
Friend EORTC 2012-11-08Sage Base
 
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Gul Muneer
 
Crowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen Science
Crowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen ScienceCrowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen Science
Crowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen ScienceAndrew Su
 
D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...
D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...
D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...Atai Rabby
 
CRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowCRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowHorizonDiscovery
 
Visual Exploration of Clinical and Genomic Data for Patient Stratification
Visual Exploration of Clinical and Genomic Data for Patient StratificationVisual Exploration of Clinical and Genomic Data for Patient Stratification
Visual Exploration of Clinical and Genomic Data for Patient StratificationNils Gehlenborg
 
Systems Biology Approaches to Cancer
Systems Biology Approaches to CancerSystems Biology Approaches to Cancer
Systems Biology Approaches to CancerRaunak Shrestha
 

Similar a NetBioSIG2014-Talk by Traver Hart (20)

OKC Grand Rounds 2009
OKC Grand Rounds 2009OKC Grand Rounds 2009
OKC Grand Rounds 2009
 
PIIS089662731300319X
PIIS089662731300319XPIIS089662731300319X
PIIS089662731300319X
 
Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...Next Generation Sequencing and its Applications in Medical Research - Frances...
Next Generation Sequencing and its Applications in Medical Research - Frances...
 
Genomics Technologies
Genomics TechnologiesGenomics Technologies
Genomics Technologies
 
Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12
Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12
Stephen Friend Koo Foundation / Sun Yat-Sen Cancer Center 2012-03-12
 
20140613 Analysis of High Throughput DNA Methylation Profiling
20140613 Analysis of High Throughput DNA Methylation Profiling20140613 Analysis of High Throughput DNA Methylation Profiling
20140613 Analysis of High Throughput DNA Methylation Profiling
 
Ransbotyn et al PUBLISHED (1)
Ransbotyn et al PUBLISHED (1)Ransbotyn et al PUBLISHED (1)
Ransbotyn et al PUBLISHED (1)
 
A New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The ClinicA New Generation Of Mechanism-Based Biomarkers For The Clinic
A New Generation Of Mechanism-Based Biomarkers For The Clinic
 
Stephen Friend WIN Symposium 2011 2011-07-06
Stephen Friend WIN Symposium 2011 2011-07-06Stephen Friend WIN Symposium 2011 2011-07-06
Stephen Friend WIN Symposium 2011 2011-07-06
 
Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...Detecting clinically actionable somatic structural aberrations from targeted ...
Detecting clinically actionable somatic structural aberrations from targeted ...
 
Friend EORTC 2012-11-08
Friend EORTC 2012-11-08Friend EORTC 2012-11-08
Friend EORTC 2012-11-08
 
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
Proteogenomic analysis of human colon cancer reveals new therapeutic opportun...
 
CE-Symm jLBR talk
CE-Symm jLBR talkCE-Symm jLBR talk
CE-Symm jLBR talk
 
Crowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen Science
Crowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen ScienceCrowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen Science
Crowdsourcing Biology: The Gene Wiki, BioGPS, and Citizen Science
 
D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...
D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...
D4476, a cell-permeant inhibitor of CK1, potentiates the action of Bromodeoxy...
 
CRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and HowCRISPR Screening: the What, Why and How
CRISPR Screening: the What, Why and How
 
Visual Exploration of Clinical and Genomic Data for Patient Stratification
Visual Exploration of Clinical and Genomic Data for Patient StratificationVisual Exploration of Clinical and Genomic Data for Patient Stratification
Visual Exploration of Clinical and Genomic Data for Patient Stratification
 
Systems Biology Approaches to Cancer
Systems Biology Approaches to CancerSystems Biology Approaches to Cancer
Systems Biology Approaches to Cancer
 
Grindberg - PNAS
Grindberg - PNASGrindberg - PNAS
Grindberg - PNAS
 
Seminar on crispr
Seminar on crisprSeminar on crispr
Seminar on crispr
 

Más de Alexander Pico

NRNB Annual Report 2018
NRNB Annual Report 2018NRNB Annual Report 2018
NRNB Annual Report 2018Alexander Pico
 
NRNB Annual Report 2017
NRNB Annual Report 2017NRNB Annual Report 2017
NRNB Annual Report 2017Alexander Pico
 
2016 Cytoscape 3.3 Tutorial
2016 Cytoscape 3.3 Tutorial2016 Cytoscape 3.3 Tutorial
2016 Cytoscape 3.3 TutorialAlexander Pico
 
NRNB Annual Report 2016: Overall
NRNB Annual Report 2016: OverallNRNB Annual Report 2016: Overall
NRNB Annual Report 2016: OverallAlexander Pico
 
Technology R&D Theme 3: Multi-scale Network Representations
Technology R&D Theme 3: Multi-scale Network RepresentationsTechnology R&D Theme 3: Multi-scale Network Representations
Technology R&D Theme 3: Multi-scale Network RepresentationsAlexander Pico
 
Technology R&D Theme 2: From Descriptive to Predictive Networks
Technology R&D Theme 2: From Descriptive to Predictive NetworksTechnology R&D Theme 2: From Descriptive to Predictive Networks
Technology R&D Theme 2: From Descriptive to Predictive NetworksAlexander Pico
 
Technology R&D Theme 1: Differential Networks
Technology R&D Theme 1: Differential NetworksTechnology R&D Theme 1: Differential Networks
Technology R&D Theme 1: Differential NetworksAlexander Pico
 
Overall Vision for NRNB: 2015-2020
Overall Vision for NRNB: 2015-2020Overall Vision for NRNB: 2015-2020
Overall Vision for NRNB: 2015-2020Alexander Pico
 
2015 Cytoscape 3.2 Tutorial
2015 Cytoscape 3.2 Tutorial2015 Cytoscape 3.2 Tutorial
2015 Cytoscape 3.2 TutorialAlexander Pico
 
NetBioSIG2014-FlashJournalClub by Frank Kramer
NetBioSIG2014-FlashJournalClub by Frank KramerNetBioSIG2014-FlashJournalClub by Frank Kramer
NetBioSIG2014-FlashJournalClub by Frank KramerAlexander Pico
 
NetBioSIG2014-Intro by Alex Pico
NetBioSIG2014-Intro by Alex PicoNetBioSIG2014-Intro by Alex Pico
NetBioSIG2014-Intro by Alex PicoAlexander Pico
 
NetBioSIG2014-Talk by Tijana Milenkovic
NetBioSIG2014-Talk by Tijana MilenkovicNetBioSIG2014-Talk by Tijana Milenkovic
NetBioSIG2014-Talk by Tijana MilenkovicAlexander Pico
 
NetBioSIG2014-Talk by Yu Xia
NetBioSIG2014-Talk by Yu XiaNetBioSIG2014-Talk by Yu Xia
NetBioSIG2014-Talk by Yu XiaAlexander Pico
 
NetBioSIG2014-Keynote by Marian Walhout
NetBioSIG2014-Keynote by Marian WalhoutNetBioSIG2014-Keynote by Marian Walhout
NetBioSIG2014-Keynote by Marian WalhoutAlexander Pico
 
NetBioSIG2014-Talk by Ashwini Patil
NetBioSIG2014-Talk by Ashwini PatilNetBioSIG2014-Talk by Ashwini Patil
NetBioSIG2014-Talk by Ashwini PatilAlexander Pico
 
Visualization and Analysis of Dynamic Networks
Visualization and Analysis of Dynamic Networks Visualization and Analysis of Dynamic Networks
Visualization and Analysis of Dynamic Networks Alexander Pico
 
NRNB Annual Report 2013
NRNB Annual Report 2013NRNB Annual Report 2013
NRNB Annual Report 2013Alexander Pico
 
Introduction to WikiPathways
Introduction to WikiPathwaysIntroduction to WikiPathways
Introduction to WikiPathwaysAlexander Pico
 
Network Visualization and Analysis with Cytoscape
Network Visualization and Analysis with CytoscapeNetwork Visualization and Analysis with Cytoscape
Network Visualization and Analysis with CytoscapeAlexander Pico
 
NetBioSIG2013-KEYNOTE Michael Schroeder
NetBioSIG2013-KEYNOTE Michael SchroederNetBioSIG2013-KEYNOTE Michael Schroeder
NetBioSIG2013-KEYNOTE Michael SchroederAlexander Pico
 

Más de Alexander Pico (20)

NRNB Annual Report 2018
NRNB Annual Report 2018NRNB Annual Report 2018
NRNB Annual Report 2018
 
NRNB Annual Report 2017
NRNB Annual Report 2017NRNB Annual Report 2017
NRNB Annual Report 2017
 
2016 Cytoscape 3.3 Tutorial
2016 Cytoscape 3.3 Tutorial2016 Cytoscape 3.3 Tutorial
2016 Cytoscape 3.3 Tutorial
 
NRNB Annual Report 2016: Overall
NRNB Annual Report 2016: OverallNRNB Annual Report 2016: Overall
NRNB Annual Report 2016: Overall
 
Technology R&D Theme 3: Multi-scale Network Representations
Technology R&D Theme 3: Multi-scale Network RepresentationsTechnology R&D Theme 3: Multi-scale Network Representations
Technology R&D Theme 3: Multi-scale Network Representations
 
Technology R&D Theme 2: From Descriptive to Predictive Networks
Technology R&D Theme 2: From Descriptive to Predictive NetworksTechnology R&D Theme 2: From Descriptive to Predictive Networks
Technology R&D Theme 2: From Descriptive to Predictive Networks
 
Technology R&D Theme 1: Differential Networks
Technology R&D Theme 1: Differential NetworksTechnology R&D Theme 1: Differential Networks
Technology R&D Theme 1: Differential Networks
 
Overall Vision for NRNB: 2015-2020
Overall Vision for NRNB: 2015-2020Overall Vision for NRNB: 2015-2020
Overall Vision for NRNB: 2015-2020
 
2015 Cytoscape 3.2 Tutorial
2015 Cytoscape 3.2 Tutorial2015 Cytoscape 3.2 Tutorial
2015 Cytoscape 3.2 Tutorial
 
NetBioSIG2014-FlashJournalClub by Frank Kramer
NetBioSIG2014-FlashJournalClub by Frank KramerNetBioSIG2014-FlashJournalClub by Frank Kramer
NetBioSIG2014-FlashJournalClub by Frank Kramer
 
NetBioSIG2014-Intro by Alex Pico
NetBioSIG2014-Intro by Alex PicoNetBioSIG2014-Intro by Alex Pico
NetBioSIG2014-Intro by Alex Pico
 
NetBioSIG2014-Talk by Tijana Milenkovic
NetBioSIG2014-Talk by Tijana MilenkovicNetBioSIG2014-Talk by Tijana Milenkovic
NetBioSIG2014-Talk by Tijana Milenkovic
 
NetBioSIG2014-Talk by Yu Xia
NetBioSIG2014-Talk by Yu XiaNetBioSIG2014-Talk by Yu Xia
NetBioSIG2014-Talk by Yu Xia
 
NetBioSIG2014-Keynote by Marian Walhout
NetBioSIG2014-Keynote by Marian WalhoutNetBioSIG2014-Keynote by Marian Walhout
NetBioSIG2014-Keynote by Marian Walhout
 
NetBioSIG2014-Talk by Ashwini Patil
NetBioSIG2014-Talk by Ashwini PatilNetBioSIG2014-Talk by Ashwini Patil
NetBioSIG2014-Talk by Ashwini Patil
 
Visualization and Analysis of Dynamic Networks
Visualization and Analysis of Dynamic Networks Visualization and Analysis of Dynamic Networks
Visualization and Analysis of Dynamic Networks
 
NRNB Annual Report 2013
NRNB Annual Report 2013NRNB Annual Report 2013
NRNB Annual Report 2013
 
Introduction to WikiPathways
Introduction to WikiPathwaysIntroduction to WikiPathways
Introduction to WikiPathways
 
Network Visualization and Analysis with Cytoscape
Network Visualization and Analysis with CytoscapeNetwork Visualization and Analysis with Cytoscape
Network Visualization and Analysis with Cytoscape
 
NetBioSIG2013-KEYNOTE Michael Schroeder
NetBioSIG2013-KEYNOTE Michael SchroederNetBioSIG2013-KEYNOTE Michael Schroeder
NetBioSIG2013-KEYNOTE Michael Schroeder
 

Último

The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxseri bangash
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusNazaninKarimi6
 
Concept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfConcept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfCherry
 
PODOCARPUS...........................pptx
PODOCARPUS...........................pptxPODOCARPUS...........................pptx
PODOCARPUS...........................pptxCherry
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceAlex Henderson
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxCherry
 
Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Cherry
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptxArvind Kumar
 
module for grade 9 for distance learning
module for grade 9 for distance learningmodule for grade 9 for distance learning
module for grade 9 for distance learninglevieagacer
 
FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.takadzanijustinmaime
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCherry
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .Poonam Aher Patil
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...Scintica Instrumentation
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxRenuJangid3
 
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....muralinath2
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cherry
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.Cherry
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learninglevieagacer
 

Último (20)

The Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptxThe Mariana Trench remarkable geological features on Earth.pptx
The Mariana Trench remarkable geological features on Earth.pptx
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
Concept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfConcept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdf
 
PODOCARPUS...........................pptx
PODOCARPUS...........................pptxPODOCARPUS...........................pptx
PODOCARPUS...........................pptx
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
Genome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptxGenome sequencing,shotgun sequencing.pptx
Genome sequencing,shotgun sequencing.pptx
 
Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.Selaginella: features, morphology ,anatomy and reproduction.
Selaginella: features, morphology ,anatomy and reproduction.
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptx
 
Early Development of Mammals (Mouse and Human).pdf
Early Development of Mammals (Mouse and Human).pdfEarly Development of Mammals (Mouse and Human).pdf
Early Development of Mammals (Mouse and Human).pdf
 
module for grade 9 for distance learning
module for grade 9 for distance learningmodule for grade 9 for distance learning
module for grade 9 for distance learning
 
FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
 
Factory Acceptance Test( FAT).pptx .
Factory Acceptance Test( FAT).pptx       .Factory Acceptance Test( FAT).pptx       .
Factory Acceptance Test( FAT).pptx .
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
 
LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.LUNULARIA -features, morphology, anatomy ,reproduction etc.
LUNULARIA -features, morphology, anatomy ,reproduction etc.
 
Site Acceptance Test .
Site Acceptance Test                    .Site Acceptance Test                    .
Site Acceptance Test .
 
Module for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learningModule for Grade 9 for Asynchronous/Distance learning
Module for Grade 9 for Asynchronous/Distance learning
 

NetBioSIG2014-Talk by Traver Hart

  • 1. Functional genomics and cancer subtyping with a human cancer coessentiality network Traver Hart Laboratory of Jason Moffat Donnelly Centre, U. Toronto NetBio SIG, 11 July 2014
  • 2. GI correlation networks Costanzo & Baryshnikova, et al., 2010
  • 3. GI correlation networks Gene a Gene b Gene c Gene d Gene e Cellline1 Cellline2 Cellline3 Cellline4 Cellline5 Cellline12 Cellline6 Cellline7 Cellline8 Cellline9 Cellline10 Cellline11 Essential Nonessential In yeast, highly correlated profiles imply shared gene function. Can be used to infer function of unknown genes. Hypothesis: Correlated essentiality profiles across human cancer cell lines (bottom) are analogous to correlated GI profiles and imply shared function— even if we don’t know the query strain Corollary: Gene clusters can help identify cell lines with similar vulnerabilities, possibly leading to novel classification Dixon et al., 2009 Query strains ArraygenesArraystrains Query strains
  • 4. Pooled library shRNA screens Marcotte et al., 2012
  • 6. The “daisy model” & core essential genes Hart et al., 2014
  • 7. A quantitative measure of sensitivity to RNAi perturbation Correlation, Essentiality Score vs Expression Density Gene a Gene b Gene c Gene d Gene e Cellline1 Cellline2 Cellline3 Cellline4 Cellline5 Cellline12 Cellline6 Cellline7 Cellline8 Cellline9 Cellline10 Cellline11 Essential Nonessential Query cell lines Hart et al., 2014
  • 8. Mean essentiality score Std.Devessentialityscore F-measure Number of Cell Lines NumberofCellLinesNumberofEssentialGenes
  • 9. Optimize LLS vs KEGG 30 BrCa Luminal + Her2 24 BrCa Basal 34 OvCa 15 PDAC Filtered data: 107 total screens 2,842 genes Correlations at 1% FDR: 1,086 genes F65 F50 No hairpin norm. Achilles Correlation pair rank LogLikelihoodScore(vsKEGG) 4 other
  • 13. Expression vs. Essentiality Correlation coefficient GENE CORR P-VAL SPDEF 0.716 2.00e-17 FOXA1 0.624 6.73e-13 ERBB2 0.583 4.57e-11 MDM2 0.529 7.87e-09 TFAP2C 0.463 5.12e-07 FUBP1 0.428 4.33e-06 ESR1 0.411 9.39e-05 CCND1 0.410 1.17e-05
  • 16. Functional genomics (MLL2) Homolog of GrpE, NEF of Hsp70-type ATPases Mitochondrial Hsp70 family
  • 17. Conclusions: • The human cancer coessentiality network – Depends critically on the new scoring scheme derived from Hart et al, 2014 – Optimized by lessons learned from the yeast GI network • Clusters identify cell lines with common genetic vulnerabilities – Known and novel • Co-essentiality implies Co-functionality – A unique functional genomics resource Open questions: • Identify genomic drivers of validated clusters? • Improve coverage? • Improve accuracy? CRISPR?
  • 18. Robert Rottapel Fabrice Sirculomb Fernando Suarez Mauricio Medrano Josee Normand Jason Moffat Troy Ketela Kevin Brown Judice Koh Glauber Brito Azin Sayid Dina Karamboulas Dewald Van Dyk Dahlia Kasimer Christine Misquitta Acknowledgements Essentiality Screens in Cancer Cell Lines 18 Yaroslav Fedyshyn Marianna Luhova Bohdana Fedyshyn Patricia Mero Christine Misquitta Franco Vizeacoumar Benjamin Neel Richard Marcotte Azin Sayad
  • 19. CoEssential + CoElution 850 PPI 218 neg 313? 17 PPI 60 neg 236 ? Vs CORUM Vs GO_CC GENE1 GENE2 CoEss CoElu GO_CC? Notes DLST OGDH 0.75 0.97 ? aKG dehydrogenase MRPL22 MRPL23 0.66 0.52 0 Mitochondrial EIF2B2 EIF2B3 0.62 0.91 1 EIF2B complex MRPL23 SSBP1 0.59 0.70 ? Mitochondrial HCCS SSBP1 0.57 0.42 ? Mitochondrial NACA RPLP2 0.56 0.61 ? Translation ICT1 MRPL22 0.55 0.68 0 Mitochondrial ATP5B CYC1 0.53 0.59 ? Mitochondrial ICT1 PTCD3 0.53 0.70 ? Mitochondrial EML4 MAU2 0.52 0.41 0 Microtubule associated protein / sister chromatid cohesion factor NSMCE1 SMC5 0.52 0.51 1 SMC5/6 complex COPB2 COPG1 0.51 0.98 1 Coatomer complex NUTF2 RAN 0.50 0.73 1 Nuclear pore/transport NUP205 NUP93 0.50 0.61 1 Nuclear pore/transport ATP5A1 CYC1 0.50 0.79 ? Mitochondrial ARCN1 COPB1 0.49 0.99 1 Coatomer complex EBNA1BP2 NIFK 0.49 0.60 ? Ribosome biogenesis? Mitosis? BRIX1 UTP15 0.49 0.80 ? Ribosome biogenesis EIF3C PTBP3 0.48 0.47 ? EIF3 / Polypyrimidine (RNA) binding GRPEL1 HSPA9 0.47 0.48 ? HSP70 + nucleotide exchange factor CYC1 PTCD3 0.47 0.68 ? Mitochondrial EIF5A HNRNPK 0.46 0.68 0 Translation / Splicing CYC1 UQCRC1 0.45 0.41 ? Mitochondrial CYC1 ECSIT 0.45 0.50 ? Mitochondrial ATP5B UQCRC1 0.44 0.57 0 Mitochondrial
  • 20. Why Gene Essentiality? • Context-sensitive essentials are candidate therapeutic targets Kaelin WG, Nat Rev Cancer, 2005 Wildtype A Oncogenic a Targeted b

Notas del editor

  1. Assume the NetBio SIG audience is familiar with this network… Key finding of the yeast GI network is that correlated GI profiles imply cofunctionality Question driving my research is, how can we get this kind of information for humans?
  2. In yeast, the network is generated by systematic assay of double knockout mutants or TS alleles for essential genes Systematic work like this has been very difficult in humans, though it has been attempted on modest scales by a couple of labs. However, there does exist a significant body of gene essentiality data for human cancer cell lines. Our hypothesis was that correlated gene essentiality profiles across these cell lines would produce similar information about shared biological function, and further that we may be able to discover novel patterns of shared genetic vulnerability across the cell lines assayed. Here the data represent either a binary measure of essentiality or quantitative measure of gene sensitivity to perturbation
  3. The data comes from pooled library shRNA screens where multiple shRNA hairpins targeting nearly every protein coding gene are introduced into a cell line. hairpins targeting essential genes drop out of the population and register as strong negative fold change using either a custom microarray or sequencing readout. The initial data are from screens of 72 cancer cell lines of pancreatic, ovarian, and breast origin.
  4. We have recently completed a reanalysis of this initial data set; it was just published at the beginning of this month and so I won’t go into great detail here. Briefly, we derived gold standard reference sets of essential and nonessential genes that we can use to train a Bayesian classifier—the observed fold changes of hairpins targeting a given gene are judged to be drawn from either the reference essential or nonessential distributions and the posterior log odds ratio is used as an essentiality score. Just as importantly, we can evaluate the quality of each screen using withheld reference data and identify which screens should be removed from downstream work.
  5. This work led us to the ‘daisy model’ of essentiality, where the essential genes in each cell line or tissue are represented by a petal. Petals overlap to varying degrees but they all share the same set of core essential genes; the degree to which a screen recapitulates this core is then a measure of its quality. This model is supported by whole organism data: when separated into core and peripheral essentials, only peripheral essentials are enriched for disease genes. Likewise core essentials show much lower rates of putative deleterious mutation in human population genetic data, indicating that at an organismal level we can’t stand even minor perturbation of these core essential genes.
  6. A surprising finding was that, in general, essentiality is not correlated with gene expression, as measure by RNAseq. Even more surprising was the exception to this rule: core essentials show a strong negative correlation. This may be explained by there being some minimum expression requirement for these genes; at this minimum, the genes are very sensitive to perturbation. At higher expression levels, this sensitivity is buffered. Imporantly, this led us to the conclusion that our scoring scheme was yielding a quantitative measure of gene essentiality – or sensitivity – I’ll use those terms interchangeably. So we used these scores directly in our matrix.
  7. Despite our improved scoring scheme, the essentiality data are still quite noisy. While each cell line had a fairly modest FDR of around 15%, across over 100 cell lines false positives accumulated rapidly. Here we leaned on the lessons from the yeast network to create a high-confidence coessentiality network. Using a log likelihood enrichment score against the KEGG database as a scoring scheme, we tweaked several parameters – what quality threshold to apply to the screens, what minimum number of cell lines a gene was called essential in, and the overall variance of a gene’s essentiality profile across all cell lines – to maximize that score.
  8. By rank ordering correlations at each threshold, binning in groups of 1000, and calculating the LLS vs KEGG, we get a measure of how each threshold performed. In the end, the top 107 cell lines with matching RNAseq data and genes essential in at least 4 cell lines yielded top correlations that showed about an 18-fold enrichment in KEGG pairs, and that’s after excluding the big bias-inducing sets like ribosome, proteasome, spliceosome. Taking all pairs positive correlations with FDR < 1% yielded a correlation network with 1,086 genes…
  9. And here it is. The giant connected component of the human coessentiality network. 866 genes, with an average degree of a little over 4. Four major annotations are highlighted, to show that it is not dominated by the Big Three. Naturally, when you build a network, the first thing you want to do is tear it apart to see what’s in it.
  10. Unsupervised clustering of the network yields clusters that are obviously functionally coherent (generally monochromatic). This is a very nice validation of the idea that coessentiality implies cofunctionality. The obvious next question here is, what groups of cell lines drive these clusters? Do each of these represent specific classes of genetic vulnerability? I’ll go into detail on these top two clusters; the first has no annotation of note and the second is clearly enriched for genes involved in the mitochondrial process of oxidative phosphorylation.
  11. This is the first cluster, comprising over 30 genes. Each gene’s essentiality profile is shown in this heatmap (left), with green or better representing high confidence essential. This column represents the tissue or subtype of the cell line. Light and medium blue are luminal and HER2 amplified breast cancer cell lines. So this cluster accurately discriminates these subtypes from the other data. A closer look at the genes in the cluster shows SPDEF, TFAP2C, FOXA1, CDK4, CCND1– the known oncogenes driving this subtype. Discovery of this cluster is a strong validation of our approach.
  12. It is worth noting that, despite the general trend that essentiality is not correlated with expression level, the genes in this BrCa cluster show strong positive correlation (note far out on tail of blue curve). These genes show subtype-specific expression (or overexpression) as well as essentiality but unfortunately do not indicate a general trend.
  13. The second cluster is enriched for oxphos genes. These genes are essential in a mix of breast and ovarian cancer cell lines, showing that these clusters aren’t merely differentiating tissues of origin. A closer look shows that nearly all of the genes show mitochondrial localization…
  14. Going into a bit more detail, we see that the entire oxphos pathway as well as its biogenesis is recovered. There are genes involved in mitochondrial import and mitochondrial genome transcription, the mitochondrial ribosome, and elements of four of the five oxphos complexes, plus cytochrome c and the enzyme that covalently attaches the heme group to the cytochrome. This is exactly what you’d expect from a classical genetic screen. This cluster implies that these cell lines are critically dependent on oxphos for proliferation. This is a very surprising finding, since the Warburg effect involves switching to glycolysis and away from oxphos dependence. Moreover, these genes show no correlation between essentiality and expression level; basically there is no molecular signature that predicts this dependence among these cell types.
  15. I’ve focused on the cancer implications of the major clusters in this network. In fact one of the minor clusters fine tunes the BrCa cluster; the ERBB2/ERBB3 cluster differentiates Her2-amplified cell lines from other luminal BrCa lines. Turning to a more functional genomics oriented view, we can see other evidence that coessentiality implies confunctionality. Here we have three subunits of the Cops9 signalosome complex, and all three subunits of the KGDH enzyme, a key step in the TCA cycle. This last example shows a putative connection between an Hsp70 chaperone and its associated nucleotide exchange factor. This specific interaction is not annotated in BioGrid, CORUM, or GO, but the cofactor is a homolog of both yeast and bacterial genes with the same function. [if time permits: Moreover, in a global assay of protein complexes by large-scale coelution that we performed in collaboration with Andrew Emili’s lab, we identified these two proteins as having a moderate probability of interacting.] This example represents only one of many strong predictions of cofunctionality that come out of this network.
  16. A more focused approach uses synthetic lethality to find candidate therapeutic targets. In this example, Gene B is essential only in the context of the somatic mutation in allele a, not wildtype A, and a therapy that targets B should in principle preferentially destroy cancer cells. As noted in this review, the ability to screen for these context-specific essentials has grown in concert with the availability of reagents to do systematic perturbation screens in human cells.